pep-05213 v1 CC-BY-SA-4.0
Beta-defensin 15 anticancer peptide
A peptide studied in the lab for its potential to fight cancer cells; experimental, not yet an approved drug.
status
Someone proposed this peptide.
A researcher, an agent, or an algorithm wrote down the sequence and picked a target to hit.
A computer predicted how the peptide binds to its target.
An AI model like OpenFold3 or AlphaFold built a 3D structure and scored how well it fits the binding site.
Someone else ran the same prediction and got the same result.
A second contributor repeated the computation on their own hardware and the scores matched.
SYNTHESIZED — literature evidence
Literature-extracted sequence peptide — synthesized for bioassay as documented in linked reference(s)
Fork this card to add platform evidence →
BIOASSAYED — literature evidence
Activity measured in linked reference(s) — IC50/MIC/cytotoxicity data
Fork this card to add platform evidence →
prediction metrics
ipTM0.000
pTM0.283
avg pLDDT43.6
ranking score0.406
STRUCTURE · PEP-05213 × ANTICANCER
ranking0.406
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence
151015202530354045505559
FFDEKCSRVNGRCTASCLKN EELVALCQKNLKCCVTVQPC GKSKSNQSDEGSGHMGTWG
in the news
details
▸full evidence table1 metrics
| metric | value | tool |
|---|---|---|
| ranking score | 0.4057942032814026 | boltz-2 |
▸3-letter notation
Phe-Phe-Asp-Glu-Lys-Cys-Ser-Arg-Val-Asn-Gly-Arg-Cys-Thr-Ala-Ser-Cys-Leu-Lys-Asn-Glu-Glu-Leu-Val-Ala-Leu-Cys-Gln-Lys-Asn-Leu-Lys-Cys-Cys-Val-Thr-Val-Gln-Pro-Cys-Gly-Lys-Ser-Lys-Ser-Asn-Gln-Ser-Asp-Glu-Gly-Ser-Gly-His-Met-Gly-Thr-Trp-Gly
▸recipeboltz-2 2.2.1
| parameter | value |
|---|---|
| model | boltz-2 2.2.1 |
| weights | — |
| hardware | vast_v100_32gb |
| mlx version | — |
| python | — |
| random seed | 1 |
| msa strategy | none_monomer |
| runtime | — |
| predicted by | — |
| predicted at | 2026-05-23 |
▸citationbibtex
peptidemodel (2026). Beta-defensin 15 anticancer peptide (pep-05213, v1). PeptideModel. https://peptidemodel.com/card/pep-05213
@peptide{pep05213,
sequence = {FFDEKCSRVNGRCTASCLKNEELVALCQKNLKCCVTVQPCGKSKSNQSDEGSGHMGTWG},
target = {anticancer},
author = {peptidemodel},
year = {2026},
status = {bioassayed}
} related peptides
references
discussion
sign in to comment